A detailed history of Silvant Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Silvant Capital Management LLC holds 414,654 shares of EW stock, worth $27.2 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
414,654
Previous 372,497 11.32%
Holding current value
$27.2 Million
Previous $35.6 Million 7.6%
% of portfolio
1.72%
Previous 1.72%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$84.3 - $94.31 $3.55 Million - $3.98 Million
42,157 Added 11.32%
414,654 $38.3 Million
Q1 2024

Apr 30, 2024

BUY
$72.54 - $95.56 $4.84 Million - $6.38 Million
66,744 Added 21.83%
372,497 $35.6 Million
Q4 2023

Jan 25, 2024

SELL
$61.71 - $77.76 $117,680 - $148,288
-1,907 Reduced 0.62%
305,753 $23.3 Million
Q3 2023

Oct 24, 2023

SELL
$69.28 - $93.38 $46,694 - $62,938
-674 Reduced 0.22%
307,660 $21.3 Million
Q2 2023

Jul 25, 2023

BUY
$81.41 - $94.33 $43,472 - $50,372
534 Added 0.17%
308,334 $29.1 Million
Q1 2023

Apr 26, 2023

SELL
$74.26 - $84.51 $1.42 Million - $1.62 Million
-19,141 Reduced 5.85%
307,800 $25.5 Million
Q4 2022

Jan 23, 2023

SELL
$68.3 - $87.44 $603,908 - $773,144
-8,842 Reduced 2.63%
326,941 $0
Q3 2022

Nov 09, 2022

BUY
$82.37 - $107.29 $24.8 Million - $32.3 Million
300,973 Added 864.62%
335,783 $27.7 Million
Q2 2022

Aug 03, 2022

BUY
$86.5 - $128.27 $4,584 - $6,798
53 Added 0.15%
34,810 $3.31 Million
Q1 2022

May 05, 2022

SELL
$101.96 - $128.34 $43,231 - $54,416
-424 Reduced 1.21%
34,757 $4.09 Million
Q4 2021

Feb 07, 2022

SELL
$106.37 - $130.68 $166,681 - $204,775
-1,567 Reduced 4.26%
35,181 $4.56 Million
Q3 2021

Nov 08, 2021

SELL
$102.91 - $122.75 $711,108 - $848,202
-6,910 Reduced 15.83%
36,748 $4.16 Million
Q2 2021

Aug 03, 2021

SELL
$83.84 - $104.76 $61,454 - $76,789
-733 Reduced 1.65%
43,658 $4.52 Million
Q1 2021

May 11, 2021

SELL
$78.68 - $90.67 $102,992 - $118,687
-1,309 Reduced 2.86%
44,391 $3.71 Million
Q4 2020

Feb 05, 2021

SELL
$71.69 - $91.23 $695,106 - $884,566
-9,696 Reduced 17.5%
45,700 $4.17 Million
Q3 2020

Nov 09, 2020

SELL
$67.19 - $87.44 $968,946 - $1.26 Million
-14,421 Reduced 20.66%
55,396 $4.42 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $2.59 Million - $3.47 Million
45,041 Added 181.79%
69,817 $4.83 Million
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $24,894 - $38,475
-475 Reduced 1.88%
24,776 $4.67 Million
Q4 2019

Feb 10, 2020

SELL
$71.7 - $82.09 $25,453 - $29,141
-355 Reduced 1.39%
25,251 $5.89 Million
Q3 2019

Nov 12, 2019

SELL
$61.55 - $75.43 $197,083 - $241,526
-3,202 Reduced 11.11%
25,606 $5.63 Million
Q2 2019

Aug 09, 2019

SELL
$55.74 - $64.41 $149,884 - $173,198
-2,689 Reduced 8.54%
28,808 $5.32 Million
Q1 2019

May 10, 2019

SELL
$47.89 - $64.05 $487,376 - $651,836
-10,177 Reduced 24.42%
31,497 $6.03 Million
Q4 2018

Feb 06, 2019

SELL
$46.41 - $56.94 $53,649 - $65,822
-1,156 Reduced 2.7%
41,674 $6.38 Million
Q3 2018

Nov 07, 2018

SELL
$45.7 - $58.03 $307,652 - $390,657
-6,732 Reduced 13.58%
42,830 $7.46 Million
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $23,941 - $28,933
-564 Reduced 1.13%
49,562 $7.22 Million
Q1 2018

May 09, 2018

BUY
$37.19 - $47.45 $1.86 Million - $2.38 Million
50,126 New
50,126 $6.99 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Silvant Capital Management LLC Portfolio

Follow Silvant Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.